Childhood CancerNCT02959086
Shanghai Epidemiology Study for Adolescents and Children With Cancer
An observational study of Childhood Cancer, run by Children's Cancer Group, China at 2 sites in China.
Trial summary
The purpose of this study is to describe the morbidity, mortality, disability and survival rate in Shanghai adolescents and children with cancer diagnosed since January 2002. Read more about this study
- Who is it for?
- Ages 0 to 19 years
- Conditions the study is for
- Childhood Cancer
- How many people
- 2,000 participants
- Where
- 2 sitesChina
- Study dates
- Jan 2002to Jan 2030
- How long will I take part?
- 10 Years
- Phase
- Observational
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 0 to 19 years
- All sexes
- No healthy volunteers
- Child, Adult
Study population: Since January 2002 in Shanghai, 0-19 year-old children and adolescents diagnosed with cancer.
Who may be able to join
- 0-19 year-old children and adolescents.
- Diagnosed cancer in Shanghai since January 2002.
Who cannot join
- Patients who were lost of follow-up.
- Patient's death wasn't caused by cancer or complications but by other accidents such as car accident, fell from a great height and so on.
Trial locations and contacts
2 sites in 1 country. Contact the study team or a site near you to ask about taking part.
China2 sites, 1 recruiting
- Active, not recruiting
Shanghai Children's Medical Center
Shanghai, Shanghai Municipality, 200127
- Recruiting
Shanghai Municipal Center of Disease Prevention & Control
Shanghai, Shanghai Municipality, 200336
Ying Zheng, MS,MD, 0086-21-62758710
Liang Shi, MD,MPH, 0086-21-62758710, shiliang@scdc.sh.cn
About this study
The purpose of this study is to describe the morbidity, mortality, disability and survival rate in Shanghai adolescents and children with cancer diagnosed since January 2002.
Read the detailed description
The investigators collected information of all the adolescents and children diagnosed cancer in Shanghai since January 2002, including their name, gender, the date of birth, the diagnosis date, disease diagnosis, residence address and the last follow-up time status (survival/death). The type of cancer included all malignant tumors such as Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Non-Hodgkin Lymphoma, Hodgkin Lymphoma, central nervous system tumors, Neuroblastoma, Wilms tumor and so on. Then the investigators would analyze the morbidity, mortality, disability and survival rate.
- Conditions
- Childhood Cancer
- Keywords
- Epidemiology, Shanghai, Cancer, Adolescents, Children
- Medical subject headings
- Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| 1 | Patients were diagnosed since January 2002. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Overall survival for the whole cohort
Measured: 5 years
Secondary outcomes (1)
Mortality for the whole cohort
Measured: 5 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Nov 2016 (estimated)
- Study startJan 2002
- Primary completionApr 2017
- Study completionJan 2030 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Childhood CancerStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 2,000 participants (estimated)
- Target duration
- 10 Years
Sponsor and investigators
- Lead sponsor
- Children's Cancer Group, China
- Sponsor type
- Research network
- Collaborators
- Shanghai Children's Medical Center, Shanghai Municipal Center for Disease Control and Prevention
- Responsible party
- Sponsor
- Investigators
- Yi-Jin Gao, MD, Principal investigator, Shanghai Children's Medical Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02959086
- Sponsor's protocol ID
- CCGChina
- Status last verified
- Oct 2026
- First submitted
- 7 Nov 2016
- Last updated
- 22 Oct 2026
- Results posted
- No
- Data monitoring committee
- Yes
- Individual data sharing
- No